Kolisin Neo Emulsja do wstrzykiwań
Kolisin Neo Emulsja do wstrzykiwań
Authorised
- Escherichia coli, fimbrial adhesin F4 (F4ab, F4ac, F4ad)
- Escherichia coli, fimbrial adhesin F5
- Escherichia coli, fimbrial adhesin F6
- Escherichia coli, serotype K99 (fimbrial adhesin F41), Inactivated
Product identification
Medicine name:
Kolisin Neo Emulsja do wstrzykiwań
Active substance:
- Escherichia coli, fimbrial adhesin F4 (F4ab, F4ac, F4ad)
- Escherichia coli, fimbrial adhesin F5
- Escherichia coli, fimbrial adhesin F6
- Escherichia coli, serotype K99 (fimbrial adhesin F41), Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Escherichia coli, fimbrial adhesin F4 (F4ab, F4ac, F4ad)1.00relative potency2.00millilitre(s)
-
Escherichia coli, fimbrial adhesin F51.00relative potency2.00millilitre(s)
-
Escherichia coli, fimbrial adhesin F61.00relative potency2.00metre
-
Escherichia coli, serotype K99 (fimbrial adhesin F41), Inactivated1.00relative potency2.00millilitre(s)
Pharmaceutical form:
-
Emulsion for injection/infusion
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Available in:
-
Poland
Package description:
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
- Available only in Polish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Grabikowski-Grabikowska Przedsiebiorstwo Produkcyjno-Handlowo-Uslugowe Inex Sp. j.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 2075
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022
How useful was this page?: